Site-directed Integrated Expression of EGFP Gene Based on CRISPR/Cas9 Gene Editing

Yong-yi XI,Xiao-jie WU,Yan-li LIN,Rong-bin ZHONG,Yan-rong ZHOU,Hong-xing CHEN,You-liang WANG

DOI: https://doi.org/10.13241/j.cnki.pmb.2018.19.001

2018-01-01

Abstract:Objective:To use CRISPR/Cas9 gene editing technology to achieve the site-specific integration and expression of EGFP gene in the ACTB locus of CHO cells,and establish the site-directed integration and expression of exogenous genes based on CRISPR/Cas9 technology. Methods:The CRISPR/Cas9 system was designed according to the start codon region of β-actin (ACTB) gene in CHO cells. At the same time,a homologous donor vector containing ACTB homology arm and EGFP gene was constructed. The transfection of CRISPR/Cas9 plasmid and donor vector was carried out by Liposomes transfection method. The EGFP positive cells were sorted by flow cytometry. The feasibility of gene editing in the site-specific integration and expression of EGFP gene was analyzed.Results:The CRISPR/Cas9 system effectively cut the ACTB gene of CHO cells. The EGFP expressed efficiently in the ACTB locus.After ACTB gene deletion,the compensatory expression of γ-actin was enhanced,and CHO cell growth well. Conclusions:Genomic replacement within 1 kb can be achieved by simply relying on gene editing techniques,but the efficiency is low. To achieve exogenous gene replacement of larger fragments,other experimental techniques are needed.